I don’t disagree with any of your comments. As per my opening...

I don’t disagree with any of your comments. As per my opening line, funding is definitely the question of the moment and how they traverse the funding pathway from here is critical. At the moment the share price is where it is simply due the dilution risk.

Also, yes the numbers i used are very much dartboard guesses - only designed to show that there is a possibly interesting project in Limon that also could make economic sense and hence is potentially fundable if we ever get to that stage. Having Limon is a very attractive option as otherwise the cost of developing a big porphyry is not feasible with a major taking the lions share.